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Abstract
Background: With the increasing burden of mental illness globally, it is becoming common for hospitalised
patients with chronic medical conditions to have a comorbidity of mental illness. This combination could prolong
length of stay (LOS) of this patient cohort. We conducted an investigation in Tasmania, Australian hospitals to
characterise this cohort and assess if co-morbidity of mental illness is a distinguishing factor that generates LOS
variation across different chronic medical conditions.
Methods: The retrospective study analysed 16,898 admissions of patients with a primary diagnosis of one of five
chronic medical conditions: lung or colorectal cancer, chronic obstructive pulmonary disease (COPD), type II
diabetes, ischaemic heart disease (IHD) and stroke. Data were from July 2010 to June 2015, across four hospitals
that collectively cover 95% of public hospital admissions in Tasmania, Australia. Descriptive statistics were used to
compare characteristics of patients between the scenarios of with and without co-morbidity of mental illness. We
used negative binomial regression models to assess whether co-morbidity of mental illness, along with its sub-
types, after adjustment for potential confounding variables, associated with LOS variation in patients of each
medical condition. Based on the adjusted LOS variation, we estimated differences in bed days’ use between
patients with and without comorbidity of mental illness.
Results: Patients with co-morbidity of mental illness were significantly younger in comparison to patients without
mental illness. With each medical condition, patients with comorbidity of mental illness had incurred higher bed
days’ use than for those without mental illness. In cancer and stroke cohorts, co-morbidity of mental illness
unfavourably affected the LOS variation by as high as 97% (CI: 49.9%–159%) and 109% (78%–146%), respectively.
Though mental and behavioural disorders due to psychoactive substances was a dominant sub-type of mental
illness across the medical conditions, it contributed significant unfavourable LOS variation only in the stroke
patients i.e. 36.3% (CI: 16.2%–59.9%).
Conclusions: Mental illness consistently produced unfavourable LOS variation. Upskilling of healthcare teams and
greater reporting and analysis of LOS variation for this patient cohort, and the sub-cohorts within it, are necessary
to provide improved medical care and achieve system efficiencies.
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Background
It has been reported that hospitalised patients with
chronic medical conditions and a comorbidity of mental
illness can experience a longer length of stay (LOS), in-
cluding patients with chronic obstructive pulmonary dis-
ease (COPD) [1], diabetes [2, 3], ischaemic heart disease
(IHD) [4], and stroke [5]. This outcome is poor for both
patients and the health system that strives to care for
them. Longer LOS reflects a compromise to this vulner-
able population’s quality of life and care experience, and
highlights health system inefficiencies [6, 7]. This is a
growing problem internationally, with ongoing increases
in hospitalised patients having a comorbidity of mental
illness [8–11].
A key concern is that many health jurisdictions do not
have a detailed knowledge about characteristics of pa-
tients with chronic medical disease and a comorbidity of
mental illness [12]. The knowledge deficit extends to a
lack of understanding about LOS variation and improve-
ment strategies for this cohort. LOS variation is a par-
ameter to show differences in average LOS within the
same condition between peer hospitals [13–15]. LOS
variation is a well-accepted parameter to assess effi-
ciency in hospitals in Australia [13], the United States
[16] and other Organisation for Economic Cooperation
and Developed (OECD) countries [17, 18]. As unfavour-
able LOS variation can indicate excess bed days’ use that
could have catered for more admitted patients [7]. How-
ever, it is not standard practice to report LOS variation
of patients with chronic medical conditions and a co-
morbidity of mental illness separate from that of hospi-
talised patients with a chronic medical condition only.
Furthermore, existing published information about
LOS for patients with chronic medical conditions and a
comorbidity of mental illness is limited. Studies of LOS
variation often have only examined one or two medical
conditions [4, 19, 20] and did not control for patient
characteristics or were limited to a single hospital setting
[5]. To improve care outcomes and promote efficient
functioning of the health system, we need the capability
to more specifically identify and manage hospitalised pa-
tients with chronic medical conditions and a comorbid-
ity of mental illness [11, 21–23].
To address this issue, we conducted a study investigat-
ing two research questions: first, are there differences in
characteristics of patients with chronic medical condi-
tion with and without a comorbidity of mental illness?
Second, is a comorbidity of mental illness a distinguish-
ing factor that generates LOS variation across different
chronic medical conditions? Cancer (lung and colorectal
only), COPD, diabetes (type 2), IHD and stroke are five
chronic conditions that reflect about 20% of the burden
of disease in Tasmania, Australia [24]. These five condi-
tions are also in the list of top 10 leading causes of death
in the world [25]. Accordingly, we investigated the two
research questions with patients having these five
chronic medical conditions in the context of Tasmanian
public hospitals.
Methods
Data and sources
The data related to patients admitted to any of the four
major public hospitals in Tasmania, Australia (i.e. Royal
Hobart Hospital, Launceston General Hospital, Mersey
Community Hospital, and North West Regional Hos-
pital). These four hospitals are collectively responsible
for 95% of all public hospital admissions in the Tasman-
ian state that has 500,000 inhabitants [26, 27]. In this
retrospective study, we extracted de-identified demo-
graphic and clinical information for hospital admissions
that occurred between 1 July 2010 and 30 June 2015.
We accessed the “Admitted patient care National Mini-
mum Data Set (NMDS)” for these admissions as pro-
vided by the Tasmanian Department of Health and
Human Services. The admitted patient care NMDS is a
minimum set of data elements for inpatient care that
health authorities around Australia mandatorily report
to support national collation [28, 29]. We used specific
fields from this dataset for each admission: hospital; pa-
tient sex, date of birth, date of admission and discharge
(or separation), area of residence; and a sequence of
international classification of disease (ICD)-10 codes ex-
tracted from medical records by clinical coders. One of
these ICD-10 codes from each admission was designated
as the primary diagnosis.
Study measures
We analysed data for admissions where the primary
diagnosis was one of five chronic medical conditions:
cancer (lung and colorectal only), COPD, diabetes (type
2), IHD or stroke. The next step involved further screen-
ing of the patients, to identify those with a mental illness
ICD-10 code entered as a secondary diagnosis during
the course of the admission. Table 1 shows the ICD-10
codes used to define each of the chronic medical condi-
tions and mental illnesses.
Consistent with previous reporting of mental illness,
we omitted patients with dementia (F00-F03) [31] and
delirium (F05) [31, 32] from the mental illness cohort.
Complete information on all variables was available for
over 99% of admissions, making it appropriate to ex-
clude a case (i.e. patient admission) from analysis only if
the required data for the specific analysis was missing.
Other variables computed from the extracted data
were LOS, bed days’ use, age, socioeconomic status
(SES), and presence of an additional comorbidity. The
measurement of the primary outcome measure, LOS,
was in whole days, equal to date of discharge or
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separation minus admission date. We coded LOS as zero
(0) for admissions where discharge date was the same as
admission date. Calculation of bed day’s use, which is
another outcome variable, was based on the average per-
centage increase (p) in the adjusted LOS of the negative
binomial regression run in this study. Explanation of this
calculation is provided in the statistical analysis section
of the paper. Average measures of SES for applicable
geographical regions were downloaded from the website
of the Australian Bureau of Statistics [33]. This average
measure of SES is drawn from the Index of Relative
Socio-Economic Advantage and Disadvantage (IRSAD),
a weighted average score of an area’s characteristics such
as material and social resources [34]. Data for this index
is recorded in the Australian census, standardised to a
distribution where the mean equals 1000 and standard
deviation is 100 [34]. The IRSAD score reflects an area’s
average socio-economic status rather than that of indi-
viduals living in that area [35]. Higher scores in the
index infer higher level of advantage, with areas of
higher-than-average socio-economic advantage having
scores above 1000.
Charlson comorbidity is a method to identify comor-
bidities and variation of complexity in patients with a list
of 17 comorbidities [36–38]. We used lists of ICD-10
codes validated by Quan et al. [38] to assess the presence
or absence of additional Charlson comorbidities in pa-
tients. Patients were dichotomised into group of higher
complexity when additional Charlson comorbidities were
present and vice versa for the group of low complexity.
For four of the five chronic medical conditions listed in
Table 1 (Type II diabetes, cancer, stroke and COPD), all
patients with the condition had at least one of the 17
Charlson comorbidities. Accordingly, we classified pa-
tients with these four conditions for presence or absence
of additional Charlson comorbidities other than the
Charlson comorbidity associated with the primary con-
dition. For example, patients with a primary diagnosis of
Type II diabetes were classified into those with and
without a Charlson comorbidity other than “diabetes
without chronic complication”. Similarly, patients with a
primary diagnosis of (a) cancer, (b) stroke and (c) COPD
were classified into groups of those with and without a
Charlson comorbidity other than (a) “malignancies includ-
ing lymphoma and leukaemia except malignant neoplasm
of the skin”, (b) “cerebrovascular disease” and (c) “chronic
pulmonary disease”, respectively. For the fifth condition in
Table 1 (IHD), even though there are several cardiovascu-
lar comorbidities among the 17 Charlson comorbidities by
definition, not all patients with a primary diagnosis of
IHD had one of these comorbidities. Hence, patients with
a primary diagnosis of IHD were divided simply into those
with at least one Charlson comorbidity and those without
any Charlson comorbidities.
Statistical analysis
To address the first research question, we utilised de-
scriptive statistics to compare patients within each
chronic medical condition, for scenarios of with and
without the comorbidity of mental illness. T-tests were
used to compare the means of continuous variables, and
Fisher exact tests were used to compare distributions of
binary variables.
We addressed the second research question with
stages of analyses. Firstly, negative binomial regression
was used to test for an independent association between
LOS and comorbidity of mental illness. This analysis
was run using the glm.nb() command from the “MASS”
package in R, which contains functions and datasets as-
sociated with Venables and Ripley's Modern Applied Sta-
tistics With S [39]. The analysis was adjusted for six
potential confounding factors: hospital, financial year of
separation or discharge (categorical), presence of Charl-
son comorbidity, age (5-year categories), gender and SES
(treated as a continuous variable). To test whether differ-
ent subtypes of mental illness were associated with dif-
ferent changes in LOS, the mental illness diagnoses in
Table 1 were divided into their blocks as per ICD-10
WHO version [40]: F04–F09 (excluding F05), F10–F19,
F20–29, F30–39, F40–F48, F50–F59, F60–F69, F70–F79,
F80–F89, F90–98 and F90–F99. In the model for each
chronic condition, if codes from a particular block oc-
curred in 10 or more admissions, that block was coded
as an additional binary variable (in addition to the binary
Table 1 Coverage of chronic medical conditions and mental illness in this study
Illnesses ICD-10 codes, in accordance to International statistical classification of diseases (ICD)
Chronic medical conditions as primary diagnosis Cancer: Lung cancer “C33”,“C34”; Colorectal Cancer “C18”,“C19”,“C20”,“C21”
COPD: “J44.”
Type II Diabetes: “E11”
IHD: “I20”,“I21”,“I22”,“I23”, “I24”, “I25”
Stroke: “I60”,“I61”,“I62”,“I63”,“I64”,“I65”,“I66”,“I67”,“I68”,“I69”,“G45”,“G46”
Mental illnesses as secondary diagnosis “F04”, “F06”, “F07”, “F09”, “F10–F19”, “F20–F29”, “F30–F39”, “F40–F48”, “F50–F59”,
“F60–F69”, “F70–F79”, “F80–F89”, “F90–F99”
Details of medical conditions and mental illnesses for each ICD-10 code are accessible at World Health Organisation (WHO) website [30].
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variable coding of overall presence/absence of mental ill-
ness) and added to the regression model. Backwards
stepwise regression [35] was then used to remove
non-significant blocks until all blocks remaining in the
model (if any) had Wald p-values less than 0.05.
Changes in the adjusted LOS were calculated for each
remaining significant block. The same calculation was
applied for all other sub-type of mental illnesses, that is,
the group of non-significant blocks and blocks with less
than 10 admissions.
The next stage was assessing the independent associ-
ation of comorbidity of mental illness with LOS, for dif-
ferences in usage of bed days. This aspect of the analysis
required several steps. First, we estimated the average
percentage increase (p) in adjusted LOS, associated with
mental illness (Column 5 in Table 4). This percentage
increase p is equal to (exp(b) – 1) × 100%, where b is
the coefficient of the mental illness term in the negative
binomial regression model. Then, we calculated the dif-
ference in bed days’ use, reducing the p to zero, with the
assumption of same average LOS for patients of chronic
medical conditions, between the scenarios of with and
without a comorbidity of mental illness. For example, if
we consider n patients having a comorbidity of mental
illness with a particular chronic disease (Column 1 in
Table 4) and that average LOS for these n patients is t
days (Scenario 2 in Column 2 in Table 4). Then, the esti-
mated difference in bed days’ use in five years came to
be n*t*p / (1+ p) (Column 6 in Table 4). Similarly, the
estimated bed days’ use per patient came to be t*p / (1 +
p) (Column 6 in Table 4). The estimated bed days’ use
represents the adjusted value, controlling for the influ-
ence of the confounding variables.
Results
The study sample comprised 16,898 admissions across the
five chronic disease categories. As shown in Table 2, the
most common reason for admission was IHD (n = 8,005)
and the least common was type 2 diabetes (n = 1,299).
There was great variation in the proportion of admissions
with a mental illness comorbidity between the different
chronic medical conditions. For example, the rate of
COPD admissions with a comorbidity of mental illness
was 23%, while for IHD admissions the rate was only 3%.
Comparison of patient characteristics
Patients with mental illness as a comorbidity were sig-
nificantly younger in comparison to those without men-
tal illness, across the five chronic conditions (Table 2).
The average age gap ranged between three to eight
years, with the highest age gap in the stroke cohort.
There were no significant gender differences between
mental illness and without mental illness groups across
the cohorts of chronic conditions. Socioeconomic status
between the mental illness and non-mental illness
groups only differed in the stroke cohort, where patients
with mental illness generally belonged to areas of lower
socioeconomic advantage.
In the stroke cohort, there was a significantly higher rate
of presence of Charlson comorbidity for those with mental
illness - 74%, in comparison to 57% for those without
mental illness. The presence of a Charlson comorbidity
for the patients with cancer and IHD had a similar pattern
- 83% and 83% of mental illness, in comparison to 72%
and 71% for those without mental illness, respectively.
Comorbidity of mental illness and LOS variation
Patients with a comorbidity of mental illness had different
types of mental illnesses. Table 3 shows blocks of subtype
of mental illness ICD-10 codes that occurred in 10 or
more admissions, for each chronic condition. Mental and
behavioural disorders due to psychoactive substance use
was a dominant subtype of mental illness across the five
chronic conditions. The other common, but less domin-
ant, subtype of mental illness across the five chronic con-
ditions was neurotic and stress-related disorders.
Table 4 reports the association between comorbidity
of mental illness and the LOS variation. Within each
chronic medical condition, patients with a comorbidity
of mental illness had significantly longer LOS than for
patients without mental illness (Column 2, Table 4).
The column 5 in Table 4 reports the adjusted LOS vari-
ation - that is, the percentage increase in mean LOS
distinguishably due to a comorbidity of mental illness
after controlling for probable confounding variables. In
the cohort of cancer and stroke conditions, comorbidity
of mental illness unfavourably affected the LOS vari-
ation of some patients by as high as 97% and 109%.
Though mental and behavioural disorders (due to psy-
choactive substances) was a dominant subtype of men-
tal illness across the five chronic diseases (Table 3), it
contributed a significant and disproportionate un-
favourable LOS variation only in the stroke patient co-
hort i.e. 36.3%.
In the cohort of COPD patients, the neurotic,
stress-related and somatoform disorders subtype of
mental illness markedly increased the unfavourable LOS
variation i.e. 64.2%. The diabetes and IHD cohorts did
not have any specific sub-type of mental illness that dis-
proportionately increased the LOS.
Comorbidity of mental illness reflected differences
in bed days’ use across the chronic medical condi-
tions, when we assumed the adjusted LOS variation
between the groups of with and without mental ill-
ness to be zero. The greatest difference came from
the stroke cohort, with 11.1 days of higher bed use
per patient for the mental illness group (“all other
subtypes”) than for those without mental illness. The
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mental illness groups having lower end of differences
in bed days’ use than those without mental illnesses
were COPD: 2.4 days per patient and IHD: 2.9 days
per patient. When we accumulate the scenario for all
four hospitals across the chronic medical conditions,
the differences in bed days’ use between patients with
and without concomitant mental illness over the 5
years was 3,711 (the summation of all the differences
in bed days’ use in 5 years, as reported in the last
column of Table 4).
Discussion
This study compared the characteristics of five types of
chronic medical condition patients, with and without a
Table 2. Comparison of patients with chronic medical conditions of scenario 1: admission with no diagnosed secondary mental
illness (MI) versus scenario 2: admission with a diagnosed secondary MI
Primary diagnosis recorded during admission Scenario 1: Without MI Scenario 2: With MI Difference between the scenarios
Cancer (Lung and Colorectal) (n = 1147)
Number of admissions (%) 1047 (91.3%) 100 (8.7%)
Mean age, years (SD) 70.1 (11.7) 67.1 (10.9) P = 0.01a*
No. of females (%) 424 (40%) 45 (45%) P = 0.40b
Mean Socio-Economic Index for Areac (SD) 929 (68) 925 (67) P = 0.54a
No. of admissions with at least one additional CCd (%) 759 (72%) 83 (83%) P = 0.02b*
COPD (n = 1404)
Number of admissions (%) 1084 (77%) 320 (23%)
Mean age, years (SD) 71.6 (10.3) 68.0 (10.8) P < 0.01a**
No. of females (%) 547 (50%) 163 (51%) P = 0.90b
Mean Socio-Economic Index for Areac (SD) 914 (72) 912 (67) P = 0.57a
No. of admissions with at least one additional CCe (%) 305 (28%) 86 (27%) P = 0.67b
Diabetes (type 2) (n = 1299)
Number of admissions (%) 1209 (93.1%) 90 (6.9%)
Mean age, years (SD) 64.5 (14.9) 59.5 (13.7) P < 0.01a**
No. of females (%) 390 (32%) 30 (33%) P =0.82b
Mean Socio-Economic Index for Areac (SD) 928 (74) 925 (66) P = 0.66a
No. of admissions with at least one additional CCf (%) 910 (75%) 74 (82%) P = 0.13b
Ischaemic heart disease (IHD) (n = 8005)
Number of admissions (%) 7755 (96.9%) 250 (3.1%)
Mean age, years (SD) 69.2 (13.2) 63.6 (13.6) P < 0.01a**
No. of females (%) 2586 (33%) 82 (33%) P = 0.89b
Mean Socio-Economic Index for Areac (SD) 931 (69) 923 (71) P = 0.06a
No. of admissions with at least one CC (%) 5475 (71%) 207 (83%) P < 0.01b**
Stroke (n = 5043)
Number of admissions (%) 4757 (94.3%) 286 (5.7%)
Mean age, years (SD) 72.4 (14.7) 64.4 (14.7) P < 0.01a**
No. of females (%) 2217 (46%) 119 (42%) P = 0.11b
Mean Socio-Economic Index for Areac (SD) 942 (70) 924 (75) P < 0.01a**
No. of admissions with at least one additional CCg (%) 2720 (57%) 212 (74%) P < 0.01b**
SD Standard deviation, CC Charlson comorbidity
*The variable differs significantly between the two scenarios at P < 0.05.
**The variable differs significantly between the two scenarios at P < 0.01.
aP-value calculated using a t-test
bP-value calculated using a Fisher exact test
cHigher score reflects higher level of advantage and vice versa
dOther than the Charlson comorbidity “any malignancy, including lymphoma and leukaemia, except malignant neoplasm of the skin” associated with the
primary diagnosis
eOther than the Charlson comorbidity “chronic pulmonary disease” associated with the primary diagnosis
fOther than the Charlson comorbidity “diabetes without chronic complication” associated with the primary diagnosis
gOther than the Charlson comorbidity “cerebrovascular disease” associated with the primary diagnosis
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comorbidity of mental illness. Furthermore, the study
analysed the association between comorbidity of mental
illness and the LOS variation of hospitalised patients
while controlling for confounding variables. This analysis
included assessment of difference in bed days’ use by
mental illness patients against those without mental
illness, within each chronic medical condition. To the
best of the authors’ knowledge, this is unique work in-
vestigating the adverse impact of comorbidity of mental
illness across a wide range of chronic medical conditions
in a state wide public hospital system. Existing literature
[41, 42] that reported an association between
Table 3 Subtypes of mental illness coded in 10 or more admissions of patients, for the five chronic medical conditions
Cancer COPD Diabetes IHD Stroke
Total number of patients’ admissions with a diagnosis of mental illness recorded 100 320 90 250 286
F10–F19: Mental & behavioural disorders due to psychoactive substance use 48 (48%) 219 (69%) 47 (52%) 160 (64%) 151 (53%)
F20–F29: Schizophrenia, schizotypal & delusional disorders < 10 11 (3.4%) < 10 < 10 < 10
F30–F39: Mood [affective] disorders < 10 17 (5.3%) 16 (18%) 17 (6.8%) 61 (21%)
F40–F48: Neurotic, stress-related & somatoform disorders 39 (39%) 102 (32%) 16 (18%) 66 (27%) 58 (20%)
Rarer subtypes of mental illness are not listed in the table (e.g. F60 – F69: Disorders of adult personality and behaviour). Percentages in a column can sum to
more than 100% because some admissions were coded with more than one type of mental illness
Table 4 LOS variation attributable to mental illness, for each of the five chronic medical diseases
Chronic
Disease
(number
of patients
with MI)
Mean LOS in
days in
scenarios of
1. Without MI
(SD) and
2. With MI (SD)
Type of MIa
(number of patients
with the type of MI)
Mean LOS
(SD) in days
for patients
with this
type of MI
Adjusted LOS
variationb: %
increase in mean
LOS with MI (95% CI)
Difference in Bed-days’ usec
Per patient in 5 years
Cancer
(n= 100)
Scenario 1:
8.6 (9.3)
Scenario 2**:
12.8 (11.8)
F10–F19 Mental and behavioural
disorders due to psychoactive
substance use
(n = 48)
9.5 (7.4) 14.6% (–14.3%–53.2%) NA NA
All other subtypes
(n = 52)
15.8 (14.1) 97.0% (49.9%–159%) 7.8 404
COPD
( n= 320)
Scenario 1:
4.3 (4.6)
Scenario 2*:
4.9 (4.6)
F40–F48 Neurotic, stress-related
and somatoform disorders
(n = 102)
6.2 (5.2) 64.2% (39.4%–93.4%) 2.4 248
All other subtypes
(n = 218)
4.3 (4.1) 8.2% (–4.7%–22.9%) NA NA
Diabetes
(n = 90)
Scenario 1:
5.6 (9.3)
Scenario 2**:
8.7 (8.5)
All (n = 90) 8.7 (8.5) 68.0% (29.6%–118%) 3.5 317
IHD
(n = 250)
Scenario 1:
3.2 (4.1)
Scenario 2**:
6.2 (9.6)
All (n = 250) 6.2 (9.6) 90.5% (71.5%–112%) 2.9 735
Stroke
(n= 286)
Scenario 1:
7.9 (10.8)
Scenario 2**:
16.7 (26.7)
F10–F19 Mental and behavioural
disorders due to psychoactive
substance use
(n = 151)
12.5 (28.1) 36.3% (16.2%–59.9%) 3.3 505
All other subtypes
(n = 135)
21.3 (24.4) 109% (78%–146%) 11.1 1502
MI Mental illness, SD Standard deviation, CI Confidence Interval, NA Not applicable
*The variable differs significantly between scenario 1 and 2 at P < 0.05
**The variable differs significantly between scenario 1 and 2 at P < 0.01
aPatients with MI were divided into subtypes if more than 10 admissions were coded with the subtype (see Table 3), and if there was a significant difference in
length of stay (LOS) between patients with this subtype of MI and patients with other subtypes of MI. Otherwise, results are presented for all patients with MI
grouped together as the case for diabetes and IHD
bPercentage increases in LOS, in relation to patients without MI, were estimated after adjusting for the variables: hospital, financial year of patient separation,
presence of a Charlson Comorbidity, patient age, patient gender, and socio-economic status (SES) by geographical region
cThese hypothetical difference in bed-days’ use is calculated with the assumption of same average LOS for patients of chronic medical conditions, between the
scenarios of with and without a comorbidity of MI. Difference in bed-days use were calculated based on both MI subtype (if any) and total MI (if no subtype). NA
refers to scenarios where hypothetical bed-days’ use was not calculated since no significant increase in adjusted LOS existed
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comorbidity of mental illness and LOS did not concen-
trate on such a range of chronic conditions. This study
addressed the need for greater clarification of the role of
mental illness in complex care management [12].
There are two major findings: one, the similarities
and distinctiveness of characteristics of patients with
and without a comorbidity of mental illness varied
across the chronic medical conditions, such as cancer
versus diabetes; and, two, the consistent influence of
mental illness on unfavourable LOS variation of pa-
tients with chronic medical conditions. The degree to
which the comorbidity of mental illness influenced
the LOS varied across the chronic medical conditions.
In certain conditions, such as cancer, COPD and
stroke, the influence of comorbidity of mental illness
on LOS also varied with subtype of mental illness.
These findings support the previously reported associ-
ation between comorbidity of mental illness and re-
source utilisation, which could originate from
patients’ compromised cognition and involvement in
self-care and rehabilitation, or associated complexities
such as stigma [12, 41, 42]. This study was not de-
signed to explore the factors that associated length of
hospital stay to a comorbidity of mental illness, and
future studies will be beneficial in this regard.
This study identified patients with chronic medical
condition and a comorbidity of mental illness as be-
ing younger than their corresponding non-mental ill-
ness cohort. This finding resonated with certain
literature [43], but contrasted with others [3, 44]. The
2017 study by Lavin and colleagues [43], which was
in the context of acute care end-of-life patients, had
similarity with ours in not restricting the study popu-
lation by age. This is unlike the Adams et al.’s [44]
study that restricted the population of the study to 65
years and above. This may infer that studies of pa-
tients with a comorbidity of mental illness and
chronic medical conditions can identify a relatively
younger cohort of patients when there is no age re-
striction on the study population.
The unfavourable LOS variation for patients with
chronic medical conditions, in association with a comor-
bidity of mental illness, is similar to previous literature
[1–5, 19, 44]. For example, Krein et al [2] reported an
increase in LOS of around four days in patients with dia-
betes and a comorbidity of mental illness, which is com-
parable with our finding of three and a half days
difference in bed use. This small difference is perhaps
explained by our analysis including a broad scope of
mental illnesses (i.e. all of the applicable ICD-10 F codes
reported in Table 1), whereas Krein’s research included
patients with comorbidities of severe mental illness only.
Notwithstanding, the projected differences in bed days
use in this study is consistent with the recent literature
that reported substantial bed days saving through bench-
marking to the average LOS of peer hospitals [7].
Implications
The findings of this study imply opportunities for com-
mon care processes in areas where chronic disease pa-
tients with and without mental illness are similar.
Application of such common processes will require flexi-
bility in acute care models for patients with chronic
medical conditions and a comorbidity of mental illness.
This need for flexibility aligns with current policy guid-
ance for integrated and patient-centred care with mental
health and multimorbidity conditions [8, 11, 45, 46].
Joint health and behavioural risk education for common
issues between the two cohorts seems an efficient strat-
egy [10, 11]. In areas where the two cohorts are differ-
ent, such as the significant age differences found across
the five chronic diseases in this study, distinctive care
processes that accommodate age-specific risk factors are
applicable [47]. These distinctive processes should be
about integrating care for medical and mental illnesses
for a relatively younger cohort, so that care for this co-
hort does not become more complex with progressing
age [48]. Therefore, health professionals will strengthen
the tasks of integration and patient centeredness if they
are capable of switching between common and distinct-
ive care processes. We understand the switching be-
tween common and distinctive processes will also
require upskilling of healthcare teams. This upskilling
will potentially include unlearning the rigidity of strict
clinical specialism [49]. Additionally, health professionals
will need to rely on collaboration skills for practices such
as effective engagement between general hospital staff
and psychiatric liaison teams [50].
The reported LOS variation highlights the necessity
for LOS improvement strategies for chronic disease pa-
tients with a comorbidity of mental illness. Hospitals will
save substantial bed-days by levelling the bed days’ use
of this vulnerable population to that of patients only
with chronic medical conditions. However, the LOS im-
provement strategies should work towards improved
care in a realistic manner. A portion of the differences in
bed days’ use will not usually translate to reduced cost
or be available for use, accommodating for contingent
bed capacity and required quality of care [51, 52]. LOS
efficiency practices need to consider a hospital’s mix of
different types of chronic diseases and comorbidities of
subtype of mental illness. For example, in our study,
COPD and diabetes showed similar differences in bed
days’ use over five years, despite diabetes having one bed
day higher difference per patient - as Tasmanian hospi-
tals manage higher number of admissions of patients
with a comorbidity of mental illness and COPD. The
study found that the same subtype of mental illness
Siddiqui et al. BMC Health Services Research  (2018) 18:498 Page 7 of 10
(mental and behavioural disorders due to psychoactive
substance use) influenced bed days’ use in a varied man-
ner between chronic medical conditions such as cancer
and stroke. Hence, a hospital’s mix of comorbidities of
medical and mental illnesses will influence efficiency
gains from different LOS efficient practices, such as bet-
ter planning of discharges and patient flow [53]. Findings
in our study confirm that a relatively small health sys-
tem, catering to a population of about 500,000, could
make substantial savings in bed days, from LOS efficient
practices with chronic medical disease patients with co-
morbidity of mental illness. Again, a challenge is upskill-
ing of healthcare teams [54], for quality sensitive
implementation of initiatives directed at bed days saving.
Another implication is the need for policy guidance
that facilitates routine reporting and monitoring of LOS
variation between chronic medical condition patients
with and without mental illness. Open evidence of un-
favourable LOS variation between peer hospitals should
empower health professionals to develop strategies to
minimise any unwarranted variation [55, 56].
Government-led initiatives, such as the OECD health
care variation study and the Australian atlas of health-
care variation, are examples in this regard [15, 57, 58].
Increased transparency about the influence of mental ill-
ness on LOS variation can strengthen evidence for
chronic disease and mental health service research, con-
tributing to better system-based approaches for multi-
morbidity and patient equity in the long-term [59].
There were a few study limitations, particularly regard-
ing availability of data. For example, the SES of admitted
patients was a generalisation based on the average so-
cio-economic status of the area of residence of individuals,
and individuals can have different socio-economic status
to that of the area average. We may not have captured all
acute patients of comorbidities of physical and mental ill-
ness, as there can be misses in coding of a diagnosis of
mental illness in patients admitted for chronic medical
conditions [60]. The adjusted LOS variation data in this
study accounted for six probable confounding variables
but there could be more confounding factors, such as a
patient’s use of mental illness services prior to hospital
admission.
Conclusion
Patients with and without a comorbidity of mental ill-
ness can have similar and distinctive characteristics
across primary medical conditions of cancer, COPD, dia-
betes, IHD and stroke. Comorbidity of mental illness
consistently produced unfavourable LOS variation across
these five medical conditions. There is need for im-
proved integrated care models and efficiency in LOS for
patients with chronic medical conditions and comorbid-
ity of mental illness. Given that this vulnerable
population is growing, we need greater policy guidance
for widespread reporting and analysis of LOS variation
of this patient cohort. Upskilling of associated healthcare
teams is also a necessity in this regard. We hope this
study will generate interest for future studies about ways
to attain the same LOS for acute care patients with
chronic medical conditions, regardless of their mental
health status.
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